Back to TopTreatment Overview
Radiation therapy is the use of high-dose X-rays to destroy cancer
cells. Radiation therapy may be used to treat
endometrial cancer after
hysterectomy or as the primary therapy, particularly
for women who cannot have surgery. The two types of
radiation therapy that may be used to treat
endometrial cancer are:
- Internal radiation therapy (brachytherapy), in
which radioactive materials (radioisotopes) are placed into the uterus or other
areas where the cancer cells are found.
- External beam radiation
therapy, in which radiation comes from a machine outside the body.
Back to TopWhat To Expect After Treatment
In brachytherapy, tiny tubes of radioactive material are
inserted through the vagina and left in the uterus for
2 to 3 days. Brachytherapy may be done in the hospital or as on an outpatient
basis.
External beam radiation therapy is usually done in an outpatient
treatment center. A typical therapy course is radiation treatments 5 days a
week for 4 to 6 weeks.
Radiation therapy may cause side effects, including:
- Fatigue.
- Dryness, itching,
tightening, and burning in the vagina.
- Red, dry, tender, itchy
skin.
- Moist, weepy skin (later in the treatment).
- Hair
loss in the treated area.
- Loss of
appetite.
- Diarrhea.
- Frequent and uncomfortable
urination.
- Reduced white blood cell count.
For long-term side effects, see the Risks section below.
Radiation therapy may make sexual intercourse uncomfortable. You
may have to wait until after treatment is finished to resume sexual
intercourse.
Back to TopWhy It Is Done
Radiation therapy is usually given after surgery (adjuvant therapy) for endometrial cancer. Adjuvant
radiation may be recommended for women who have a high risk for the spread of
the cancer. If a woman cannot undergo surgery, she may receive radiation
therapy alone, but cure rates are slightly lower than with surgery.
Radiation therapy may be used at different points of treatment,
depending on the
stage
and grade of the endometrial cancer.
- Stage I: Radiation therapy is not usually used
if surgery effectively removes the cancer. If cancer is found deep in the
uterine muscle (myometrium), radiation of the pelvis may be
given.
- Stage II: Radiation therapy may be used before or after
surgery. If cancer is present in the
cervix, radiation may be used after
surgery.
- Stage III: Radiation therapy and surgery are the standard
treatment options. If surgery is not recommended, radiation therapy alone may
be used. Radiation therapy may also be used if more extensive cancer is
discovered during surgery.
- Stage IV: Radiation therapy may be used
if the cancer is contained in the pelvic region but is usually not recommended
if the cancer has spread (metastasized) to other parts of the body.
Endometrial cancer may recur. Radiation therapy may be used to
control symptoms and increase comfort. Radiation therapy may cure your cancer
if the cancer is confined to your vagina and radiation therapy has not been
used before.
Back to TopHow Well It Works
Radiation therapy for endometrial cancer is used primarily as
adjuvant therapy with surgery (hysterectomy and bilateral
salpingo-oophorectomy). It is usually not recommended unless you have a high
risk of cancer spreading beyond the uterus. Adjuvant radiation therapy can
reduce cancer recurrence in the pelvis and vagina.1, 2
Back to TopRisks
Having radiation therapy to any part of the pelvis can cause side
effects such as bladder irritation. These side effects may stop after treatment
is finished.
Other side effects of radiation can include:3
- Bowel obstruction.
- Abdominal
cramps.
- Frequent bowel movements or diarrhea.
- Chronic
bladder irritation.
- Vaginal scarring (vaginal fibrosis).
Back to TopWhat To Think About
For some women with stage 3 or 4 cancer, chemotherapy with radiation may work better than radiation alone.4
Radiation therapy to the pelvis causes permanent sterility. If your
cancer is in a very early stage and is low grade (slow-growing) and you want to
be able to have children, progestin hormone therapy may be an option rather
than a hysterectomy and/or radiation therapy.
Complete the
special treatment information form (PDF)
(What is a PDF document?)
to help you understand this treatment.
Back to TopReferences
Citations
Cannistra SA (2004). Gynecologic cancer. In DC Dale,
DD Federman, eds., Scientific American Medicine, vol. 3,
part 12, chap. 10, pp. 9–11. New York: WebMD.
Creutzberg CL, et al. (2003). Survival after relapse
in patients with endometrial cancer: Results from a randomized trial.
Gynecologic Oncology, 89: 201–209.
Creutzberg CL, et al. (2000). Surgery and
postoperative radiotherapy versus surgery alone for patients with stage-1
endometrial carcinoma: Multicentre randomised trial. Lancet, 355: 1404–1411.
Randall ME, et al. (2006). Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Journal of Clinical Oncology, 24(1): 36–44.
Back to TopCredits
| Author | Kathe Gallagher, MSW |
| Editor | Alison Allen |
| Editor | Kathleen M. Ariss, MS |
| Associate Editor | Pat Truman |
| Primary Medical Reviewer | Joy Melnikow, MD, MPH - Family Medicine |
| Specialist Medical Reviewer | Ross Berkowitz, MD - Obstetrics and Gynecology |
| Last Updated | November 27, 2006 |
Cannistra SA (2004). Gynecologic cancer. In DC Dale,
DD Federman, eds., Scientific American Medicine, vol. 3,
part 12, chap. 10, pp. 9–11. New York: WebMD.
Creutzberg CL, et al. (2003). Survival after relapse
in patients with endometrial cancer: Results from a randomized trial.
Gynecologic Oncology, 89: 201–209.
Creutzberg CL, et al. (2000). Surgery and
postoperative radiotherapy versus surgery alone for patients with stage-1
endometrial carcinoma: Multicentre randomised trial. Lancet, 355: 1404–1411.
Randall ME, et al. (2006). Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study. Journal of Clinical Oncology, 24(1): 36–44.